Your browser doesn't support javascript.
loading
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Lane, Thirusha; Fontana, Marianna; Martinez-Naharro, Ana; Quarta, Candida Cristina; Whelan, Carol J; Petrie, Aviva; Rowczenio, Dorota M; Gilbertson, Janet A; Hutt, David F; Rezk, Tamer; Strehina, Svetla G; Caringal-Galima, Joan; Manwani, Richa; Sharpley, Faye A; Wechalekar, Ashutosh D; Lachmann, Helen J; Mahmood, Shameem; Sachchithanantham, Sajitha; Drage, Edmund P S; Jenner, Harvey D; McDonald, Rosie; Bertolli, Ottavia; Calleja, Alan; Hawkins, Philip N; Gillmore, Julian D.
Affiliation
  • Lane T; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Quarta CC; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Whelan CJ; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Rowczenio DM; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Gilbertson JA; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Hutt DF; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Rezk T; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Strehina SG; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Caringal-Galima J; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Manwani R; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Sharpley FA; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Lachmann HJ; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Sachchithanantham S; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Drage EPS; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
  • Jenner HD; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
  • McDonald R; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
  • Bertolli O; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
  • Calleja A; Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
  • Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
  • Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.).
Circulation ; 140(1): 16-26, 2019 07 02.
Article in En | MEDLINE | ID: mdl-31109193
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Amyloid Neuropathies, Familial / Cardiomyopathies Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Amyloid Neuropathies, Familial / Cardiomyopathies Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2019 Document type: Article